Neuropsychiatry companies develop treatments, diagnostics and research technologies for conditions involving the interaction between brain function, behaviour and mental health. Their work spans psychiatric disorders, neurological symptoms and central nervous system drug discovery.
This category includes companies working on:
Browse 13 UK neuropsychiatry companies below.
Natural product-inspired small molecules for sexual and mental health
Kadence Bio is a clinical-stage biopharma company developing small molecule therapeutics for sexual and mental health. Its lead asset KH-001 is an on-demand oral treatment for…
Clinical-stage CNS drug discovery using human brain genomics
Cerevance is a clinical-stage biotechnology company developing small molecule therapeutics for neurodegenerative and psychiatric disorders. The company uses its proprietary…
Real-world mental health and dementia data platform for drug development
Akrivia Health is a software company providing a real-world data and AI platform for neuroscience research and drug development. Its dataset of de-identified electronic health…
Precision medicine biotech targeting psychiatric and neurological conditions
Monument Therapeutics is a clinical-stage biotechnology company applying precision medicine to CNS drug development. The company uses proprietary digital biomarkers to stratify…
Synthetic psilocybin therapy for treatment-resistant depression and PTSD
Compass Pathways is a clinical-stage biopharmaceutical company developing synthetic psilocybin-based treatments for mental health conditions. Its lead candidate, COMP360, is a…
Neuroactive therapeutics through genetic engineering of fungi and plants
Empyrean Neuroscience is a biopharma company that uses genetic engineering of fungi and plants to develop small molecule therapeutics for neuropsychiatric and neurologic…
Specialist CNS and psychiatric clinical trial design and delivery organisation
Clerkenwell Health is a London-based specialist contract research organisation providing clinical trial design, regulatory submission, and trial delivery services for CNS,…
AI-powered EEG platform for CNS clinical trials
Cumulus Neuroscience is a digital health software company providing an integrated brain monitoring and analytics platform for neuroscience clinical trials. Its platform combines a…
Digital cognitive assessment and CNS clinical trial software platform
Cambridge Cognition is a software company providing digital cognitive assessment and clinical trial technology for central nervous system drug development. Its validated…
Stem cell platform for precision psychiatry and drug discovery
MeOmics Precision Medicine is a biotechnology company developing a precision psychiatry platform that combines genomics, phenomics, and stem cell-based cellular assays to generate…
Small molecule neuromodulators for neuropsychiatric disorders
Draig Therapeutics is a clinical-stage biotech developing small molecule drugs that modulate the glutamate and GABA neurotransmitter pathways to treat neuropsychiatric disorders.…
Precision small molecule drugs for obsessive-compulsive disorder
Serenatis Bio is a preclinical-stage biotech developing small molecule drugs to treat obsessive-compulsive disorder (OCD). Its pipeline of three candidates targets distinct…